275 related articles for article (PubMed ID: 16389038)
1. Circulating angiogenic proteins in trisomy 13.
Bdolah Y; Palomaki GE; Yaron Y; Bdolah-Abram T; Goldman M; Levine RJ; Sachs BP; Haddow JE; Karumanchi SA
Am J Obstet Gynecol; 2006 Jan; 194(1):239-45. PubMed ID: 16389038
[TBL] [Abstract][Full Text] [Related]
2. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
[TBL] [Abstract][Full Text] [Related]
3. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
4. Circulating angiogenic factors in singleton vs multiple-gestation pregnancies.
Maynard SE; Moore Simas TA; Solitro MJ; Rajan A; Crawford S; Soderland P; Meyer BA
Am J Obstet Gynecol; 2008 Feb; 198(2):200.e1-7. PubMed ID: 18226624
[TBL] [Abstract][Full Text] [Related]
5. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes.
Coolman M; Timmermans S; de Groot CJ; Russcher H; Lindemans J; Hofman A; Geurts-Moespot AJ; Sweep FC; Jaddoe VV; Steegers EA
Obstet Gynecol; 2012 Jun; 119(6):1190-200. PubMed ID: 22617584
[TBL] [Abstract][Full Text] [Related]
7. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
[TBL] [Abstract][Full Text] [Related]
8. High early pregnancy body mass index is associated with alterations in first- and second-trimester angiogenic biomarkers.
Beck C; Allshouse A; Silver RM; Grobman WA; Simhan H; Haas D; Reddy UM; Blue NR
Am J Obstet Gynecol MFM; 2022 May; 4(3):100614. PubMed ID: 35283347
[TBL] [Abstract][Full Text] [Related]
9. Early pregnancy angiogenic markers and spontaneous abortion: an Odense Child Cohort study.
Andersen LB; Dechend R; Karumanchi SA; Nielsen J; Joergensen JS; Jensen TK; Christesen HT
Am J Obstet Gynecol; 2016 Nov; 215(5):594.e1-594.e11. PubMed ID: 27287686
[TBL] [Abstract][Full Text] [Related]
10. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia.
Vatten LJ; Eskild A; Nilsen TI; Jeansson S; Jenum PA; Staff AC
Am J Obstet Gynecol; 2007 Mar; 196(3):239.e1-6. PubMed ID: 17346536
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis.
Chaemsaithong P; Gil MM; Chaiyasit N; Cuenca-Gomez D; Plasencia W; Rolle V; Poon LC
Am J Obstet Gynecol; 2023 Sep; 229(3):222-247. PubMed ID: 36990308
[TBL] [Abstract][Full Text] [Related]
12. Prediction of imminent preeclampsia at 35-37 weeks gestation.
Ciobanu A; Wright A; Panaitescu A; Syngelaki A; Wright D; Nicolaides KH
Am J Obstet Gynecol; 2019 Jun; 220(6):584.e1-584.e11. PubMed ID: 30738886
[TBL] [Abstract][Full Text] [Related]
13. Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia.
Unal ER; Robinson CJ; Johnson DD; Chang EY
Am J Obstet Gynecol; 2007 Aug; 197(2):211.e1-4. PubMed ID: 17689655
[TBL] [Abstract][Full Text] [Related]
14. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
[TBL] [Abstract][Full Text] [Related]
15. First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia.
Odibo AO; Rada CC; Cahill AG; Goetzinger KR; Tuuli MG; Odibo L; Macones GA; England SK
J Perinatol; 2013 Sep; 33(9):670-4. PubMed ID: 23558430
[TBL] [Abstract][Full Text] [Related]
16. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
Shibata E; Rajakumar A; Powers RW; Larkin RW; Gilmour C; Bodnar LM; Crombleholme WR; Ness RB; Roberts JM; Hubel CA
J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
[TBL] [Abstract][Full Text] [Related]
17. Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1.
Bdolah Y; Elchalal U; Natanson-Yaron S; Yechiam H; Bdolah-Abram T; Greenfield C; Goldman-Wohl D; Milwidsky A; Rana S; Karumanchi SA; Yagel S; Hochner-Celnikier D
Hypertens Pregnancy; 2014 May; 33(2):250-9. PubMed ID: 24304210
[TBL] [Abstract][Full Text] [Related]
18. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.
Masuyama H; Suwaki N; Nakatsukasa H; Masumoto A; Tateishi Y; Hiramatrsu Y
Am J Obstet Gynecol; 2006 Feb; 194(2):551-6. PubMed ID: 16458660
[TBL] [Abstract][Full Text] [Related]
19. Human chorionic gonadotropin, angiogenic factors, and preeclampsia risk: a nested case-control study.
Asvold BO; Eskild A; Vatten LJ
Acta Obstet Gynecol Scand; 2014 May; 93(5):454-62. PubMed ID: 24575980
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE
J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
